Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia

J Eur Acad Dermatol Venereol. 2001 Sep;15(5):418-21. doi: 10.1046/j.1468-3083.2001.00315.x.

Abstract

Background: Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia) for androgenetic alopecia are much less common than reported in the literature.

Objective: To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF).

Methods: The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia and 236 age-matched males attending the Department of Dermatology of the University of Bologna.

Results: Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls.

Conclusions: The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Alopecia / diagnosis
  • Alopecia / drug therapy*
  • Case-Control Studies
  • Erectile Dysfunction / chemically induced*
  • Erectile Dysfunction / diagnosis
  • Erectile Dysfunction / epidemiology
  • Finasteride / administration & dosage
  • Finasteride / adverse effects*
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Probability
  • Reference Values
  • Risk Assessment

Substances

  • Finasteride